Selective neurodegeneration in Alzheimer's disease and Parkinson's disease
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are featured by cholinergic and dopaminergic neuron loss, respectively. As a unique pathological hallmark of AD, neuritic plaques contain aggregated amyloid β protein (Aβ), generated from amyloid β precursor protein (APP). APP mutations cause fam...
Main Author: | Wang, Juelu |
---|---|
Language: | English |
Published: |
University of British Columbia
2017
|
Online Access: | http://hdl.handle.net/2429/63267 |
Similar Items
-
Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease
by: Anmu Xie, et al.
Published: (2014-01-01) -
Mechanisms of Neurodegeneration and Neuroprotection in Parkinson’s and Alzheimer's Disease
by: Ismael, Sazan Khalid
Published: (2019) -
The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
by: Ana I. Ramirez, et al.
Published: (2017-07-01) -
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
by: Federico Paolini Paoletti, et al.
Published: (2021-05-01) -
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
by: Sean Hong Tan, et al.
Published: (2019-03-01)